INSM vs. SRPT

In the year-to-date period, INSM achieves a 1.19% return, which is significantly lower than SRPT's 3.87% return. Over the past 10 years, INSM has underperformed SRPT with an annualized return of 16.43%, while SRPT has yielded a comparatively higher 24.57% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Insmed Incorporated (INSM) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current INSM Sharpe Ratio is 1.14, which is higher than the SRPT Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of INSM and SRPT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither INSM nor SRPT has paid dividends to shareholders.

The maximum INSM drawdown since its inception was -98.65%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for INSM and SRPT. For additional features, visit the drawdowns tool.

Insmed Incorporated (INSM) has a higher volatility of 9.42% compared to Sarepta Therapeutics, Inc. (SRPT) at 7.22%. This indicates that INSM's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Insmed Incorporated and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.